A series of 1-phenyl-3-(4-(2-ethanoloxy) phenyl)-5-aryl-1H-pyrazoles were synthesized from chalcones, that is, 3-aryl-1-(4-hydroxyphenyl) prop-2-en-1-ones and studied for their in vitro antibacterial activity. Chalcones 1 on reaction with phenyl hydrazine in the presence of acetic acid and few drops of hydrochloric acid yielded the corresponding 1-phenyl-3-(4-hydroxyphenyl)-5-aryl-1H-pyrazoles 2 which on further reaction with 2-chloroethanol furnished the title compounds 3. ese compounds were characterized by CHN analyses, IR, mass and 1 H NMR spectral data. All the compounds were evaluated for their in vitro antibacterial activity against two Gram positive strains (Bacillus subtilis and Staphylococcus aureus) and two Gram negative strains (Escherichia coli and Pseudomonas aeruginosa), and their minimum inhibitory concentration (MIC) was determined.
Introduction
e extensive utilization of chemotherapeutic agents for the management of infectious diseases leads to the development of microbial resistance to existing drugs. e appearance of resistance to the major classes of antibacterial drugs is recognized as a major health concern of world population. is opens the gate for the medicinal chemists for the development of novel antimicrobial drugs having a different mechanism of action to combat the problem of multidrug resistance [1] . Heterocyclic compounds continue to attract considerable interest due to their diverse biological activities. Amongst them �ve membered heterocyclic compounds occupy a uni�ue place in the �eld of natural and synthetic organic chemistry. Five membered heterocycles like pyrazoles have been found to display wide application as pharmaceutical and agrochemical agents. In recent years, attention has increasingly been given to the synthesis of pyrazole derivatives as a source of new antibacterial agents. Pyrazole derivatives have been reported to possess diverse biological activities such as antibacterial [2, 3] , antifungal [4, 5] , herbicidal [6] , insecticidal [7] , anti-in�ammatory [8, 9] anticonvulsant [10] , antitumor [11] , anti-oxidant [12] and so forth. Further, 1H-pyrazoles containing phenoxy propanol [13] and phenoxy butanol [14] side chain have been reported to possess antibacterial activity by us as a part of our ongoing research program in the �eld of synthesis and antimicrobial activity of medicinally important heterocyclic compounds [15, 16] . ese reports inspired us to undertake the synthesis of some 1H-pyrazoles bearing phenoxy ethanol moiety. e synthesized compounds were characterized on the basis of elemental analysis, IR, 1 H NMR and mass spectral data. All the compounds were screened for their in vitro antibacterial activity against two Gram positive strains (Bacillus subtilis and Staphylococcus aureus) and two Gram negative strains (Escherichia coli and Pseudomonas aeruginosa), respectively.
Experimental
2.1. Chemistry. e purity of all the synthesized compounds was checked by thin-layer chromatography on silica gel G as a stationary phase and different solvent systems as a mobile phase using iodine vapors as detecting agent. Melting points were determined by the Tempo melting point determination apparatus in open capillary tubes and are uncorrected. Elemental analyses were carried out on Perkin Elmer 2400 CHN Elemental Analyser. Infrared spectra were recorded on Shimadzu 8000 FTIR Spectrophotometer in KBr phase. Proton NMR spectra were done on Bruker Avance II 400 NMR Spectrometer using tetramethyl silane as internal standard. Mass spectra of the compounds were carried out on Waters Micromass Q-Tof Micro Mass Spectrometer using electrospray ionization (ESI) technique. Chalcones 1a-g were synthesized by a base-catalyzed Claisen-Schmidt condensation reaction of appropriately substituted benzaldehydes and p-hydroxy acetophenone [17] , and 1-phenyl-3-(4-hydroxyphenyl)-5-aryl-1H-pyrazoles 2a-g were prepared from the chalcones 1a-g following the procedure described in the literature [18] . 
General Procedure for the

1-Phenyl-3-(4-(2-ethanoloxy) phenyl)-5-(4-methylphenyl)-1H-pyrazole (3b)
:
1-Phenyl-3-(4-(2-ethanoloxy) phenyl)-5-(4-methoxy-phenyl)-1H-pyrazole (3c):
Yield: 64%; m.p.: 95-97 ∘ C; IR (KBr, and Pseudomonas aeruginosa (MTCC 2453), respectively. Cipro�oxacin was used as the standard drug for the present study. Serial two-fold dilution technique was used for the study of antibacterial activity [19] . A stock solution (10 g/mL) of all the title compounds and standard drug was prepared in dimethyl sulfoxide. Sterilized double-strength nutrient broth (DSNB) was used as a growth media. e stock solution was serially diluted by DSNB aseptically to give concentrations of 5.0-0.01 g/mL into a series of sterilized culture tubes. All the tubes were inoculated by bacterial strain. e inoculum's size was approximately 10 colony forming units (CFU/mL). e inoculated tubes were incubated for 24 h at 37(±1) ∘ C. Aer 24 h, the inoculated culture tubes were macroscopically examined for turbidity. e culture tube showing turbidity (lower concentration) and the culture tube showing no turbidity (higher concentration) gave the minimum inhibitory concentration (MIC) for the compound. e MIC for the title compounds and the standard drug, that is, cipro�oxacin are presented in Table 1 . for aryl alkyl ethers appeared near 1255 cm −1 . e C-H stretching vibrations for methylene groups appeared in the range of 2916-2919 cm −1 , whereas bending vibrations for methylene scissoring were observed constantly at 1465 cm −1 . Aromatic C-H stretching vibrations were observed in the range of 3100-3050 cm −1 , whereas aromatic C-H bending vibrations appeared below 900 cm −1 . In case of 1 H NMR, the chemical shi value for the O-H group was observed in the range of 3.70-3.65 (ppm) and appeared as singlet (s). Aromatic protons appeared as multiplet (m) in the range of 8.33-7.08 (ppm). e methine proton of the pyrazole nucleus absorbed at 7.03-7.01 (ppm) and appeared as singlet (s). e methylene protons adjacent to the O-H group [HO-CH 2 -CH 2 -O-Ar] appeared as triplet (t) in the range of 3.59-3.51 (ppm), whereas the methylene protons adjacent to the O-Ar group [HO-CH 2 -CH 2 -O-Ar] observed at 4.33-4.06 (ppm) and also appeared as triplet (t). Aromatic methyl and methoxy protons were observed at 2.36-2.34 (ppm) and 3.85-3.83 (ppm), respectively as singlet (s). All the title compounds showed [M+H] + of 100% intensity as the molecular ion peak. Compound containing chlorine showed isotopic peak at [M+2+H]
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+ of about 35% intensity to that of parent ion peak, whereas bromo derivative showed isotopic peak at [M+2+H] + of about equal intensity. e results of elemental analyses were found in good agreement with the calculated values. Gram negative bacteria namley, E. coli and P. aeruginosa at a MIC of 0.01 g/mL and 0.25 g/mL, respectively, whereas against Gram positive bacteria namley, S. aureus and B. subtilis MIC was found to be 0.15 g/mL and 0.12 g/mL, respectively. e results of the MIC for the standard drug, cipro�oxacin, against the bacterial strains used were found to be within the range as reported in the literature [20] [21] [22] .
Conclusion
e present study describes the synthesis of a series of 1-phenyl-3-(4-(alkanoloxy) phenyl)-5-aryl-1H-pyrazoles starting from the chalcones. e compounds were characterized by modern analytical techniques such as CHN analyses, IR, mass and proton NMR spectra. All the title compounds were screened for their in vitro antibacterial activity against Bacillus subtilis; Staphylococcus aureus (Gram positive) and Escherichia coli; Pseudomonas aeruginosa (Gram negative), and their minimum inhibitory concentration (MIC) was determined. e results of antibacterial activity showed that compounds containing electron withdrawing groups for example, chloro, bromo, �uoro, or nitro were found to be more active than the compounds containing electron releasing groups such as methyl and methoxy. ese results suggest that some more compounds using different aromatic or heteroaromatic aldehydes, ketones, and haloalkanols should be synthesized and screened for their antibacterial activity to explore the possibility of 1-phenyl-3-(4-(alkanoloxy) phenyl)-5-aryl-1H-pyrazoles as a novel series of antibacterials.
